查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356754

乳房切片設備市場報告：2030 年趨勢、預測與競爭分析

Breast Biopsy Device Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

乳房切片設備趨勢與預測

到 2030 年，全球乳房切片設備市場預計將達到 21 億美元，2024 年至 2030 年年複合成長率為 5.2%。該市場的主要促進因素是罹患率的增加、微創手術設備的大量使用以及對液體切片檢查的日益偏好。全球乳房切片設備市場的未來前景廣闊，醫院、診所、實驗室、製藥和生物技術市場存在商機。

乳房切片設備市場洞察

根據 Lucintel 的預測，引導系統預計將在預測期內實現最高成長，因為它是提高切片檢查程序準確性和效率的關鍵用途。

由於擴大採用先進的診斷工具和熟練的專業人員來改善患者照護，醫院將繼續成為最大的細分市場。

由於乳癌患者數量不斷增加、有吸引力的報銷機會以及該地區強大的醫療基礎設施，預計北美地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球乳房切片設備市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球乳房切片設備市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型分類的全球乳房切片設備市場
    • 切片穿刺針
    • 引導系統
    • 切片檢查
    • 定位線
    • 檢測試劑盒
    • 液體切片儀器
    • 其他
  • 按程序分類的全球乳房切片設備市場
    • 乳房穿刺活體組織切片
    • 開放性手術乳房切片
    • 乳房切片
  • 全球乳房切片設備市場（按應用）
    • 早期癌症篩檢
    • 治療方法選擇
    • 治療監測
    • 監測復發情況
  • 全球乳房切片設備市場（依最終用途）
    • 醫院和診所
    • 調查
    • 製藥和生物技術公司
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球乳房切片設備市場（按地區）
  • 北美乳房切片設備市場
  • 歐洲乳房切片設備市場
  • 亞太地區乳房切片設備市場
  • 其他區域乳房切片設備市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按類型分類的全球乳房切片設備市場成長機會
    • 全球乳房切片市場成長機會（按程序）
    • 全球乳房切片設備市場成長機會（按應用）
    • 全球乳房切片設備市場成長機會（依最終用途）
    • 全球乳房切片設備市場成長機會（按地區）
  • 全球乳房切片設備市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球乳房切片設備市場容量擴張
    • 全球乳房切片設備市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept
簡介目錄

Breast Biopsy Device Trends and Forecast

The future of the global breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets. The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

A more than 150-page report is developed to help in your business decisions.

Breast Biopsy Device by Segment

The study includes a forecast for the global breast biopsy device by type, procedure, application, end use, and region.

Breast Biopsy Device Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Biopsy Needles
  • Guidance Systems
  • Biopsy Tables
  • Localization Wires
  • Assay Kits
  • Liquid Biopsy Instruments
  • Others

Breast Biopsy Device Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:

  • Needle Breast Biopsy
  • Open Surgical Breast Biopsy
  • Liquid Breast Biopsy

Breast Biopsy Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

Breast Biopsy Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others

Breast Biopsy Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Breast Biopsy Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies breast biopsy device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the breast biopsy device companies profiled in this report include-

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • Neogenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Breast Biopsy Device Market Insights

Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Hospital will remain the largest segment due to the rising adoption of advanced diagnostic tools and skilled professionals to improve patient care in this setting.

North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Features of the Global Breast Biopsy Device Market

Market Size Estimates: Breast biopsy device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Breast biopsy device market by various segments, such as by type, procedure, application, end use and region in terms of($B).

Regional Analysis: Breast biopsy device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, procedures, applications, end uses, and region.s for the breast biopsy device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the breast biopsy device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the breast biopsy device market size?

Answer: The global breast biopsy device market is expected to reach an estimated $2.1 billion by 2030.

Q.2. What is the growth forecast for breast biopsy device market?

Answer: The global breast biopsy device market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the breast biopsy device market?

Answer: The major drivers for this market are growing incidence of breast cancer, significant use of this device to enable less intrusive techniques, and rising preference for liquid biopsy.

Q.4. What are the major segments for breast biopsy device market?

Answer: The future of the breast biopsy device market looks promising with opportunities in the hospital & clinic, research laboratory, and pharmaceutical & biotechnology markets.

Q.5. Who are the key breast biopsy device market companies?

Answer: Some of the key breast biopsy device companies are as follows:

  • Hologic
  • Danaher
  • Argon Medical Devices
  • Merit Medical Systems
  • Menarini-Silicon Biosystems
  • Guardant Health
  • NeoGenomics
  • Sysmex Inostics
  • Sterylab
  • Biocept

Q.6. Which breast biopsy device market segment will be the largest in future?

Answer: Lucintel forecasts that guidance system is expected to witness highest growth over the forecast period due to its significant use in enhancing the accuracy and efficiency of biopsy procedures.

Q.7. In breast biopsy device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to rising breast cancer cases, availability of attractive reimbursement opportunities, and presence of robust healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the breast biopsy device market by type (biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others), procedure (needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy), application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (hospitals & clinics, research laboratories, pharmaceutical & biotechnology companies, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Breast Biopsy Device Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Breast Biopsy Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Breast Biopsy Device Market by Type
    • 3.3.1: Biopsy Needles
    • 3.3.2: Guidance Systems
    • 3.3.3: Biopsy Tables
    • 3.3.4: Localization Wires
    • 3.3.5: Assay Kits
    • 3.3.6: Liquid Biopsy Instruments
    • 3.3.7: Others
  • 3.4: Global Breast Biopsy Device Market by Procedure
    • 3.4.1: Needle Breast Biopsy
    • 3.4.2: Open Surgical Breast Biopsy
    • 3.4.3: Liquid Breast Biopsy
  • 3.5: Global Breast Biopsy Device Market by Application
    • 3.5.1: Early Cancer Screening
    • 3.5.2: Therapy Selection
    • 3.5.3: Treatment Monitoring
    • 3.5.4: Recurrence Monitoring
  • 3.6: Global Breast Biopsy Device Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Research Laboratories
    • 3.6.3: Pharmaceutical & Biotechnology Companies
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Breast Biopsy Device Market by Region
  • 4.2: North American Breast Biopsy Device Market
    • 4.2.2: North American Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.3: European Breast Biopsy Device Market
    • 4.3.1: European Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.3.2: European Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.4: APAC Breast Biopsy Device Market
    • 4.4.1: APAC Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.4.2: APAC Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others
  • 4.5: ROW Breast Biopsy Device Market
    • 4.5.1: ROW Breast Biopsy Device Market by Type: Biopsy Needles, Guidance Systems, Biopsy Tables,Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others
    • 4.5.2: ROW Breast Biopsy Device Market by End Use: Hospitals & Clinics, Research Laboratories, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Breast Biopsy Device Market by Type
    • 6.1.2: Growth Opportunities for the Global Breast Biopsy Device Market by Procedure
    • 6.1.3: Growth Opportunities for the Global Breast Biopsy Device Market by Application
    • 6.1.4: Growth Opportunities for the Global Breast Biopsy Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Breast Biopsy Device Market by Region
  • 6.2: Emerging Trends in the Global Breast Biopsy Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Breast Biopsy Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Breast Biopsy Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Hologic
  • 7.2: Danaher
  • 7.3: Argon Medical Devices
  • 7.4: Merit Medical Systems
  • 7.5: Menarini-Silicon Biosystems
  • 7.6: Guardant Health
  • 7.7: NeoGenomics
  • 7.8: Sysmex Inostics
  • 7.9: Sterylab
  • 7.10: Biocept